Balderman, S., Ignatz-Hoover, J., Brunstein, C., Saunthararajah, Y., Tomlinson, B. (2025). A Phase 1B/2A study of weekly decitabine and venetoclax treatment as maintenance therapy in high-risk myeloid malignancy patients post allogeneic stem cell transplantation. Blood. https://doi.org/10.1182/blood-2025-2510